Literature DB >> 11414705

A protective role of PKCepsilon against TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in glioma cells.

H Shinohara1, N Kayagaki, H Yagita, N Oyaizu, M Ohba, T Kuroki, Y Ikawa.   

Abstract

To elucidate the molecular mechanism(s) involved in the TRAIL-induced apoptosis sensitivity, we conducted the following experiments utilizing TRAIL-sensitive and -resistant glioma cells. We examined the expression of TRAIL receptors mRNA, but no significant differences were detected in those cells. TRAIL-resistant cells were sensitized to TRAIL-induced apoptosis by staurosporine pretreatment and preferentially expressed PKCepsilon. Since several lines of evidence suggest that PKC may play a protective role for apoptosis, we analyzed the involvement of PKCepsilon in TRAIL-induced apoptosis by an adenovirus vector expression system. We found that TRAIL susceptibility was augmented by the expression of a dominant negative PKCepsilon in TRAIL-resistant cells. Conversely, PKCepsilon introduction in TRAIL-sensitive cells resulted in the reduction of TRAIL-induced apoptosis. Taken together, these data suggest that PKCepsilon may be a regulator of susceptibility to TRAIL-induced apoptosis in gliomas and probably other malignancies. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414705     DOI: 10.1006/bbrc.2001.5104

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.

Authors:  John Meshki; M Cecilia Caino; Vivian A von Burstin; Erin Griner; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

2.  Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells.

Authors:  Hana Okhrimenko; Wei Lu; Cunli Xiang; Nathan Hamburger; Gila Kazimirsky; Chaya Brodie
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

3.  Inhibition of novel protein kinase C-epsilon augments TRAIL-induced cell death in A549 lung cancer cells.

Authors:  Matthias Felber; Jürgen Sonnemann; James F Beck
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

Review 4.  PKC signaling in glioblastoma.

Authors:  Anália do Carmo; Joana Balça-Silva; Diana Matias; Maria Celeste Lopes
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

Review 5.  Protein kinase Cepsilon makes the life and death decision.

Authors:  Alakananda Basu; Usha Sivaprasad
Journal:  Cell Signal       Date:  2007-05-01       Impact factor: 4.315

6.  Knockdown of PKCε expression inhibits growth, induces apoptosis and decreases invasiveness of human glioma cells partially through Stat3.

Authors:  Yaming Xu; Zhe Li; Can Zhang; Shiyun Zhang; Yonghua Ji; Fuxue Chen
Journal:  J Mol Neurosci       Date:  2014-06-04       Impact factor: 3.444

7.  Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).

Authors:  Rachana Garg; Jorge Blando; Carlos J Perez; HongBin Wang; Fernando J Benavides; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

8.  In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.

Authors:  D M Ashley; C D Riffkin; M M Lovric; T Mikeska; A Dobrovic; J A Maxwell; H S Friedman; K J Drummond; A H Kaye; H K Gan; T G Johns; C J Hawkins
Journal:  Br J Cancer       Date:  2008-07-01       Impact factor: 7.640

Review 9.  Protein kinase C isoforms: Multi-functional regulators of cell life and death.

Authors:  Mary E Reyland
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Protein kinase C: an attractive target for cancer therapy.

Authors:  Barbara Marengo; Chiara De Ciucis; Roberta Ricciarelli; Maria A Pronzato; Umberto M Marinari; Cinzia Domenicotti
Journal:  Cancers (Basel)       Date:  2011-02-01       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.